Liquidia Corp

LQDA

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001819576

SEC filings (opens in a new tab)

In the last 90 days, Liquidia Corp insiders filed 0 open-market purchases and 20 sales; 336 institutions reported holding it in 13F filings for Q2 2026, worth $5.78B in total; no superinvestor holds it.

Q4 2021 vs. Q3 2021

How the institutions holding Liquidia Corp changed between Q3 2021 and Q4 2021.

All holders in Q4 2021 All holders in Q3 2021

13F holders of LQDA: Q3 2021 compared with Q4 2021
Measure	Q3 2021	Q4 2021	Change
Holders	41	46	+5
Shares	10.3M	10.6M	+315.8K (+3.1%)
Value	$28.5M	$51.8M	+$23.3M (+81.9%)

New holders (13)

Institutions that held Liquidia Corp at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to LQDA in Q4 2021
Institution	Shares	Value	% of portfolio
Kynam Capital Management, LP	1,366,836	$6.66M	3.56%
Soleus Capital Management, L.P.	231,485	$1.13M	0.15%
Two Sigma Advisers, LP	192,000	$935.0K	0.00%
Acadian Asset Management LLC	125,617	$610.0K	0.00%
Knott David M Jr	74,338	$362.0K	0.14%
Pura Vida Investments, LLC	51,404	$250.0K	0.03%
Jump Financial, LLC	39,300	$191.0K	0.01%
Cubist Systematic Strategies, LLC	33,923	$165.0K	0.00%
Royal Bank of Canada	24,187	$117.0K	0.00%
Walleye Capital LLC	19,451	$95.0K	0.00%
Opaleye Management Inc.	16,800	$82.0K	0.02%
ExodusPoint Capital Management, LP	13,316	$65.0K	0.00%
Qube Research & Technologies Ltd	11,317	$55.0K	0.00%

Sold out (8)

Institutions that held Liquidia Corp at the end of Q3 2021 and filed for Q4 2021 without it.

Institutions that sold out of LQDA in Q4 2021
Institution	Shares, Q3 2021	Value, Q3 2021
NEA Management Company, LLC	2,486,062	$6.86M
Ergoteles LLC	104,733	$289.0K
HRT Financial LP	52,105	$143.0K
King Wealth	30,000	$83.0K
UBS Group AG	10,151	$28.0K
Barclays PLC	3,775	$10.0K
Tower Research Capital LLC (TRC)	2,682	$7.00K
O'Shaughnessy Asset Management, LLC	1	$0